Cipla 444 (Atazanavir Sulfate 150 mg)
Pill with imprint Cipla 444 is Blue, Capsule-shape and has been identified as Atazanavir Sulfate 150 mg. It is supplied by Cipla USA Inc..
Atazanavir is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Atazanavir 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Cipla 444
Atazanavir Sulfate
- Imprint
- Cipla 444
- Strength
- 150 mg
- Color
- Blue
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Protease inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA Inc.
- National Drug Code (NDC)
- 69097-0444
- Inactive Ingredients
-
lactose monohydrate,
crospovidone,
magnesium stearate,
gelatin,
sodium lauryl sulfate,
FD&C Blue No. 1,
FD&C Red No. 3,
FD&C Red No. 40,
titanium dioxide,
D&C Yellow No. 10,
shellac,
alcohol,
isopropyl alcohol,
butyl alcohol,
propylene glycol,
ammonia,
potassium hydroxide
Note: Inactive ingredients may vary.
More about atazanavir
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: protease inhibitors
- FDA Alerts (2)
Consumer resources
- Patient Information
- Atazanavir (Advanced Reading)
- Atazanavir Capsules
- Atazanavir Powder for Oral Suspension
- Other brands
- Reyataz
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.